Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Johnson

Vascular & Interventional Radiology Fort Myers, FL Medical Doctor

NPI 1053601229 CMS profile 1852448

8791 Conference Dr, Fort Myers, FL 33919

Open in the dashboard

General payments

$23,409

162 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, David Johnson of Fort Myers, FL is reported in the CMS Open Payments database as having received $23,409 across 162 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $18,233 44
2024 General $1,190 32
2023 General $746 27
2022 General $656 19
2021 General $795 18
2020 General $109 9
2019 General $1,680 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Johnson
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to David Johnson were reported at $18,233. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year David Johnson Vascular & Interventional Radiology median Middle half National median
2019 $1,680 $422 $125–$1,555 $163
2020 $109 $200 $68–$652 $114
2021 $795 $280 $99–$866 $132
2022 $656 $433 $137–$1,497 $149
2023 $746 $506 $152–$2,019 $160
2024 $1,190 $556 $175–$1,930 $164
2025 $18,233 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Siemens Medical Solutions USA, Inc. $15,475 6 payments
  2. Terumo Medical Corporation $2,658 30 payments
  3. Penumbra, Inc. $2,067 53 payments
  4. Inari Medical, Inc. $686 7 payments
  5. Medtronic, Inc. $494 12 payments
  6. Boston Scientific Corporation $488 20 payments
  7. Sirtex Medical Inc $376 7 payments
  8. AstraZeneca Pharmaceuticals LP $210 2 payments
  9. AngioDynamics, Inc. $194 2 payments
  10. Surefire Medical, Inc. $144 5 payments
  11. Other $616 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $12,345 6 payments
  2. Food and Beverage $5,714 153 payments
  3. Consulting Fee $5,350 3 payments
Products named General payments · program years 2019–2025
  1. Artis icono floor $11,459 4 payments
  2. ANGIO-SEAL $1,189 8 payments
  3. Indigo $1,117 4 payments
  4. FLOWTRIEVER CATHETER, S $943 10 payments
  5. Indigo System $575 23 payments
  6. Azur CX Detachable $523 14 payments
  7. PROGREAT $450 1 payment
  8. CT THROMBECTOMY SYSTEM KIT $429 4 payments
  9. GLIDESHEATH SLENDER $325 2 payments
  10. SIR-Spheres Microspheres $230 6 payments
  11. Other $2,703 89 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

782

Median for Diagnostic Radiology: 24

Drug cost

$3,443

Median for Diagnostic Radiology: $190

Branded share of claims

14.2%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methylprednisolone Generic 212 $1,380
Ciprofloxacin Hcl Generic 95 $498
Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst Brand 42 $427
Ibuprofen Generic 185 $425
Oxycodone Hcl Generic 179 $386
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 69 $328

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 309 billing codes

Paid by Medicare

$703,583

Of which drugs: $551

Medicare patients

8,393

Average age 77

Services billed

17,562

4,384 women, 4,009 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 63%
Ischemic heart disease 51%
Chronic kidney disease 37%
Diabetes 36%
Heart failure 36%
Atrial fibrillation 36%
Depression 35%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 31 3,685 $400

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

162 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record